Acadia Pharma (ACAD) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.04 --0%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
COE, BEKE, BJ, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
COE, BEKE, BJ, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.40), $0.13 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
- Citi raises Deere price target to $650, keeps Neutral rating
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
